Data Transfer from Animal Models to Humans: The Case of Persistent Organohalogens
Author Information
Author(s): Aleksander Suvorov, Larissa Takser
Primary Institution: Université de Sherbrooke
Hypothesis
Why is there a significant delay in regulatory action for persistent organohalogens like PCBs and PBDEs?
Conclusion
The study highlights that animal models often do not provide relevant data for human health studies, leading to delays in regulatory actions.
Supporting Evidence
- Animal studies often use doses much higher than what humans are exposed to.
- Many animal studies do not address the most sensitive developmental stages.
- Animal models used in studies are often not representative of human physiology.
Takeaway
Scientists looked at studies on harmful chemicals in animals to see if they help us understand their effects on humans, but they found that they often don't match up.
Methodology
The authors reviewed 807 PubMed abstracts and full texts on the toxic effects of PCBs and PBDEs in animal models.
Potential Biases
Potential bias due to reliance on electronic databases that may miss older studies.
Limitations
The study is not a systematic review and relies on existing literature, which may not capture all relevant data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website